Reports Q2 revenue $234.08M, consensus $239.69M. Ted Harris, Chairman, President and CEO of Balchem said, “We delivered solid second quarter financials with record earnings from operations and adjusted EBITDA. I am particularly pleased with the excellent performance in our Human Nutrition and Health and Specialty Products segments, both delivering strong sales and earnings growth.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BCPC:
- Is BCPC a Buy, Before Earnings?
- Balchem Corporation Announces Quarterly Conference Call for Second Quarter Financial Results on July 26, 2024
- Balchem Corporation to Present at the CJS Securities 24th Annual New Ideas Summer Conference on July 10, 2024
- Balchem Corporation to Present at the Wells Fargo Industrials Conference on June 12, 2024